ADAM9 supports regulatory T cell stability through TGF-β–SMAD signaling and is reduced in systemic lupus erythematosus
Fields of Study & Subjects
Immunodeficiency and Autoimmune Disorders
T-cell and B-cell Immunology
TGF-β signaling in diseases
Publication details
- Journal / source
- Clinical Immunology
- Publisher
- Elsevier BV
- Volume
- 285
- Pages
- 110687–110687
- Publication date
- 27 February 2026
- Language
- EN